Lloyds Bank PLC Publication of Suppl.Prospcts

RNS Number : 0785M

Lloyds Bank PLC

25 April 2024

 

 

RNS Announcement

 

Lloyds Bank plc

 

Publication of Supplementary Prospectus

 

25 April 2024

 

The following Supplementary Prospectus has been approved by the Financial Conduct Authority and is available for viewing.

 

Supplementary Prospectus dated 25 April 2024 (the Supplementary Prospectus) relating to the €60,000,000,000 Global Covered Bond Programme of Lloyds Bank plc, unconditionally and irrevocably guaranteed as to payments of interest and principal by Lloyds Bank Covered Bonds LLP.

 

The Supplementary Prospectus should be read and construed in conjunction with the prospectus dated 3 August 2023, as supplemented by the supplementary prospectus dated 26 October 2023 and 1 March 2024 (together, the Prospectus).

 

To view the Supplementary Prospectus, please paste the following URL into the address bar of your browser:

 

http://www.rns-pdf.londonstockexchange.com/rns/0785M_1-2024-4-25.pdf

 

The Supplementary Prospectus has been submitted to the National Storage Mechanism and will shortly be available for inspection at National Storage Mechanism | FCA.

For further information, please contact:

 

Investor Relations Douglas Radcliffe Group Investor Relations Director Email: [e-mail]   Pascale Dorey Director, Debt Investor Relations, Senior Funding and Covered Bonds Email: [e-mail]	[phone]     [phone]
Group Corporate Affairs Matt Smith Head of Media Relations Email: [e-mail]	[phone]

 

Lloyds Bank plc
Registered Office
25 Gresham Street
London EC2V 7HN

 

Disclaimer - Intended Addressees

 

Please note that the information contained in this announcement and the Supplementary Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom this announcement and the Supplementary Prospectus are not addressed. Prior to relying on the information contained in this announcement and the Supplementary Prospectus, you must ascertain from the Prospectus whether or not you are one of the intended addressees of the information contained in this announcement and the Supplementary Prospectus.

 

In particular, this announcement and the Supplementary Prospectus do not constitute an offer or invitation to subscribe for, or purchase, securities in the United States or in any other jurisdiction where such an offer or invitation would be unlawful. This announcement and the Supplementary Prospectus are not for distribution in the United States or to U.S. persons (as defined below) other than to qualified institutional buyers within the meaning of and in reliance on Rule 144A of the U.S. Securities Act of 1933, as amended (the Securities Act). The securities described herein have not been, and will not be, registered under the Securities Act or under any relevant securities laws of any state of the United States of America and are subject to U.S. tax law requirements. The securities may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons or to persons within the United States of America (as such terms are defined in Regulation S under the Securities Act) except pursuant to registration or an exemption from the registration requirements of the Securities Act. There will be no public offering of the securities in the United States.  For a description of the restrictions on offers and sales of the securities described herein, please refer to the Supplementary Prospectus and the Prospectus.

 

Your right to access this service is conditional upon complying with the above requirement.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

PSPFLFLFSVIEFIS